RoosterGEM™

Complete Genetic Engineering Medium for Viral & Non-Viral Applications

SKU
Product Name
Components
Size
Quantity
Price
SKU
M40200
Product Name
RoosterGEM
Components

200mL transduction medium

Size
1 Bottle
Quantity
Price
$1,055.00
SKU
M40001
Product Name
RoosterGEM 50X
Components

1mL 50X transduction medium

Size
1 Bottle
Quantity
Price
$565.00
Overview

Overview

Engineered from the ground up, RoosterGEM is a complete media built to solve key challenges in both viral and non-viral MSC and primary cell engineering.

Traditionally, genetic modification of primary cells has low efficiency of transfer requiring increased viral  and non-viral agent costs, with significant time and resources allocated to media and process optimization.

RoosterGEM is formulated to increase genetic engineering efficiencies, enabling a reduction in key raw material costs and more readily meet regulatory guidelines. RoosterGEM 50X is an in-process transduction enhancer for use in workflows, such as T-Cells, requiring native media with activators.

When paired with RoosterBio’s industrialized supply chain of high-volume Xeno-free hMSCs, ultra-productive expansion media, and cGMP-compatible processes – you enlist an end-to-end Genetic Engineering MSC-platform to streamline your transient or integrated gene transfer, de-risk your product & process development, and streamline your path to clinical translation.

Product Features

  • 200 mL RoosterGEM™ [part no. M40200]  complete medium.
  • 1 ml RoosterGEM 50X format [part no. M40001] for use as an in-process additive to native media.
  • Complete. Chemically defined.
  • GMP formulation available for translational application.
  • Increased Viral and Non-viral primary cell engineering efficiency.
  • Supported by simplified protocols to streamline process optimization.
  • Contact RoosterBio for more information on scalable 2D or 3D bioreactor genetically modified cell bank process development

*To maximize final product yield contact RoosterBio for information on low PDL cell banks.

Lentiviral transduction efficiency at Low MOI (rLV.EF1.ZsGreen1-9, MOI=2) was increased by 3 to 5-fold compared to traditional serum and xeno-free media systems. This reduction in MOI dramatically reduced lentiviral associated costs.
Increased transduction efficiencies were achieved in RoosterBio's Xeno-free RoosterVial hMSCs from multiple donors and tissue sources.
Increased transient transfection efficiencies were achieved in hMSCs using RoosterGEM.
RoosterGEM-50X as an in-process reagent for T-Cell engineering in native media.
Product Documentation & Protocols Scientific Resources Blog Articles